ArticleChinese medical journal2025

Basiliximab is superior to low dose rabbit anti-thymocyte globulin in pediatric kidney transplant recipients: The younger, the better.

Lan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.